Wall Street Zen upgraded shares of MetLife (NYSE:MET – Free Report) from a hold rating to a buy rating in a report issued on Sunday,Wall Street Zen reports.
MET has been the topic of several other research reports. Evercore reissued a “mixed” rating on shares of MetLife in a research note on Monday, August 24th. Mizuho raised their price objective on MetLife from $112.00 to $117.00 and gave the company an “outperform” rating in a research note on Thursday. Piper Sandler lifted their price objective on MetLife from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Monday, November 9th. Keefe, Bruyette & Woods boosted their target price on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Finally, Argus upped their target price on MetLife from $93.00 to $109.00 and gave the company a “buy” rating in a report on Wednesday, September 2nd. Fourteen equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $107.12.
Read Our Latest Analysis on MET
MetLife Stock Performance
NYSE MET opened at $102.67 on Friday. MetLife has a 52-week low of $67.33 and a 52-week high of $106.72. The company has a quick ratio of 0.21, a current ratio of 0.21 and a debt-to-equity ratio of 0.65. The business’s 50-day moving average price is $98.75 and its 200 day moving average price is $86.90. The firm has a market cap of $64.52 billion, a P/E ratio of 13.39, a P/E/G ratio of 0.97 and a beta of 0.79.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, beating analysts’ consensus estimates of $2.77 by $0.01. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The company had revenue of $20.52 billion for the quarter, compared to analyst estimates of $19.86 billion. During the same quarter in the previous year, the company earned $2.34 EPS. The firm’s revenue for the quarter was up 18.2% compared to the same quarter last year. On average, equities research analysts expect that MetLife will post 9.91 earnings per share for the current year.
MetLife declared that its Board of Directors has initiated a stock buyback program on Wednesday, August 5th that authorizes the company to repurchase $3 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be given a dividend of $0.5925 per share. This represents a $2.37 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Tuesday, November 3rd. MetLife’s payout ratio is currently 30.90%.
Insider Transactions at MetLife
In related news, CEO Michel Khalaf sold 187,425 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total value of $19,299,152.25. Following the sale, the chief executive officer owned 759,013 shares of the company’s stock, valued at approximately $78,155,568.61. This represents a 19.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.40% of the company’s stock.
Hedge Funds Weigh In On MetLife
A number of institutional investors have recently made changes to their positions in MET. Jump Financial LLC lifted its position in shares of MetLife by 46.2% in the third quarter. Jump Financial LLC now owns 12,708 shares of the financial services provider’s stock valued at $1,197,000 after acquiring an additional 4,017 shares in the last quarter. Flputnam Investment Management Co. increased its position in MetLife by 7.0% during the 3rd quarter. Flputnam Investment Management Co. now owns 5,882 shares of the financial services provider’s stock worth $554,000 after purchasing an additional 383 shares in the last quarter. FORA Capital LLC raised its stake in MetLife by 106.2% in the 3rd quarter. FORA Capital LLC now owns 92,822 shares of the financial services provider’s stock valued at $8,741,000 after purchasing an additional 47,809 shares during the last quarter. Pathstone Holdings LLC raised its stake in MetLife by 13.0% in the 3rd quarter. Pathstone Holdings LLC now owns 126,979 shares of the financial services provider’s stock valued at $11,956,000 after purchasing an additional 14,641 shares during the last quarter. Finally, Cornermen Financial LLC acquired a new position in MetLife in the 3rd quarter valued at about $470,000. 94.99% of the stock is owned by institutional investors and hedge funds.
MetLife News Roundup
These are some of the MET news items that stood out recently:
- Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
- Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Further Reading
- Five stocks we like better than MetLife
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
